Millennium Management’s BioTelemetry, Inc. BEAT Stock Holding History

Millennium Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-105,000	Closed	-$4.79K	–	5874
2020 Q3	$4.79K	Buy	+105,000	New	+$4.39M	0.01%	1887
2020 Q1	–	Sell	-20,000	Closed	-$926K	–	4907
2019 Q4	$926K	Buy	+20,000	New	+$866K	﹤0.01%	3044
2019 Q3	–	Sell	-5,000	Closed	-$241K	–	4798
2019 Q2	$241K	Hold	5,000	–	–	﹤0.01%	3672
2019 Q1	$313K	Buy	+5,000	New	+$343K	﹤0.01%	3530
2017 Q4	–	Sell	-10,000	Closed	-$330K	–	4317
2017 Q3	$330K	Buy	+10,000	New	+$346K	﹤0.01%	3026

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Millennium Management's BEAT Position: Q1 2021 in Review

Millennium Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 135,339 shares — an estimated $9.76M sold.

Millennium Management first reported a position in BEAT in Q3 2013 and held it in 25 quarters. The position peaked at $10.1M in Q3 2017. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Millennium Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Millennium Management sold 135,339 BioTelemetry, Inc. shares in Q1 2021, an estimated $9.76M.
Millennium Management first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 25 quarters.
Millennium Management's BioTelemetry, Inc. position peaked at $10.1M in Q3 2017.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Millennium Management's 13F filing for Q1 2021, filed 17 May 2021.